The Government of New South Wales, the University of Sydney, Chris O`Brien Lifehouse, and Tilray announced a groundbreaking research partnership today to develop a novel treatment for chemotherapy-induced nausea and vomiting (CINV). Tilray is providing a proprietary capsule formulation for the proposed trial, which will allow researchers to test an investigational product containing two active ingredients extracted from the cannabis plant, cannabidiol (CBD) and tetrahydrocannabinol (THC). Continue reading Tilray Announces a Clinical Trial Partnership in Australia →